Tip Top Poultry Recalls Chicken Products After Samples Tested Positive for Listeria
Tip Top Poultry recently issued a recall for certain restaurant-grade chicken products after a sample tested positive for listeria.
Business
Polster Considers Lawyers Proposal for Consolidated Opioid Litigation
Judge Dan Polster considers a recommended strategy for bring all locales into consolidated litigation.
McDonald’s has been a Crime Hotspot for Visitors, Employees Worldwide
McDonald’s has had its fair share of criminal activity worldwide, endangering employees and visitors.
The 5 Most Commonly Used Cybersecurity Frameworks in Healthcare
Protecting patient data is the number one priority in healthcare IT departments. Cybersecurity frameworks are one of many means experts use to reach this goal.
Too Many Lawyers Face Substance Abuse and Mental Illness
Estimates of alcohol use among lawyers hovers at 85 percent, while only 65 percent of the average population drinks alcohol. One third of all attorneys have a drinking pattern that qualifies as problematic and potentially addictive.
Online Gambling Regulation is Sweeping Through Europe in 2019
European fans of online gambling will be pleased to know that 2019 is a year of big changes in regulations. These changes will open the market and make it even safer for players.
Attract Customers Using Fitness Apps
If you are involved in any kind of health and fitness-related business, it may pay to look at developing fitness apps as a means of attracting new customers.
Amgen’s Enbrel Patents Upheld, Copycat from Novartis Denied
Amgen’s drug patent upheld and Novartis’s copycat version is denied.
Dog Goods USA Recalls Pig Ear Dog Treats Due to Salmonella Outbreak
Dog Goods USA is recalling certain types of pig ear dog treats over concerns they may be part of a multi-state salmonella outbreak.
California Seeks to Stop Pay-to-delay Generic Drug Agreements
Three of the top pharmaceutical companies have entered agreements to pay the state of California nearly $70 million to settle allegations that they “delayed drugs to keep prices high” according to California Attorney General Xavier Becerra. Most of the funds will come from Teva Pharmaceuticals ($69 million) for paying to delay a generic for Provigil,